Javascript must be enabled to continue!
Silent mutations result in HlyA hypersecretion by reducing intracellular HlyA protein aggregates
View through CrossRef
AbstractEscherichia coli is one of the most widely used hosts for the production of recombinant proteins. Extracellular protein secretion has the advantage of reducing protein aggregation and simplifying downstream purification. The introduction of five rare codons in a specific region of the α‐hemolysin (hlyA) gene previously was shown to result in eightfold improvement in secretion of HlyA via the hemolysin (Type‐I) pathway. Here we investigate the biological basis for the observed phenomenon that translation rate of HlyA protein may be related to the ability to secrete higher levels of HlyA via the Type‐I pathway. A detailed comparative analysis between a hypersecreter mutant strain (hly‐slow) and a control strain (hly‐parent) shows a significant decrease (by ∼50%) in the intracellular level of HlyA protein in the hly‐slow strain relative to the hly‐parent strain. Nearly 100% of the intracellular HlyA protein exists in the inclusion body fraction in both the strains. These results demonstrate the importance of synonymous codon changes in the context of improving HlyA secretion yield via Type‐I pathway and further illustrate that production of high levels of secreted proteins appears to require a balance between translation and secretion rate. Biotechnol. Bioeng. © 2008 Wiley Periodicals, Inc.
Title: Silent mutations result in HlyA hypersecretion by reducing intracellular HlyA protein aggregates
Description:
AbstractEscherichia coli is one of the most widely used hosts for the production of recombinant proteins.
Extracellular protein secretion has the advantage of reducing protein aggregation and simplifying downstream purification.
The introduction of five rare codons in a specific region of the α‐hemolysin (hlyA) gene previously was shown to result in eightfold improvement in secretion of HlyA via the hemolysin (Type‐I) pathway.
Here we investigate the biological basis for the observed phenomenon that translation rate of HlyA protein may be related to the ability to secrete higher levels of HlyA via the Type‐I pathway.
A detailed comparative analysis between a hypersecreter mutant strain (hly‐slow) and a control strain (hly‐parent) shows a significant decrease (by ∼50%) in the intracellular level of HlyA protein in the hly‐slow strain relative to the hly‐parent strain.
Nearly 100% of the intracellular HlyA protein exists in the inclusion body fraction in both the strains.
These results demonstrate the importance of synonymous codon changes in the context of improving HlyA secretion yield via Type‐I pathway and further illustrate that production of high levels of secreted proteins appears to require a balance between translation and secretion rate.
Biotechnol.
Bioeng.
© 2008 Wiley Periodicals, Inc.
Related Results
Photobacterium damselae subsp. damselae Major Virulence Factors Dly, Plasmid-Encoded HlyA, and Chromosome-Encoded HlyA Are Secreted via the Type II Secretion System
Photobacterium damselae subsp. damselae Major Virulence Factors Dly, Plasmid-Encoded HlyA, and Chromosome-Encoded HlyA Are Secreted via the Type II Secretion System
ABSTRACT
Photobacterium damselae
subsp.
damselae
is a marine bacterium that causes septicemia in marine animals and in hu...
Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine
Genetic conservation of hlyA determinants and serological conservation of HlyA: basis for developing a broadly cross-reactive subunit Escherichia coli alpha-hemolysin vaccine
The HlyA determinant among Escherichia coli isolates from patients with symptomatic urinary tract infection was compared in this report with a prototype HlyA encoded by pSF4000 by ...
Endothelial Protein C Receptor
Endothelial Protein C Receptor
IntroductionThe protein C anticoagulant pathway plays a critical role in the negative regulation of the blood clotting response. The pathway is triggered by thrombin, which allows ...
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
High Resolution Melt Analysis for Rapid and Cost-Effective Screening of TP53 Mutations in Patients with Myeloid Malignancies
Abstract
Background
Recent reports have highlighted an adverse impact of TP53 mutations on the prognosis of patients with myeloid malignancies. TP53 m...
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Dynamics of Mutations in Patients with ET Treated with Imetelstat
Abstract
Background: Imetelstat, a first in class specific telomerase inhibitor, induced hematologic responses in all patients (pts) with essential thrombocythemia (...
Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms
Clinical and Biological Implications of CUX1 Mutations in Myeloid Neoplasms
Abstract
Recurrent somatic mutations of CUX1 are described in myeloid neoplasms. CUX1 is located at chromosome 7q22.1; -7/del(7q) involving CUX1 locus are common abn...
Platelet components with persistent aggregates are more activated, which do not change following pre‐transfusion filtration: The
BEST
collaborative study
Platelet components with persistent aggregates are more activated, which do not change following pre‐transfusion filtration: The
BEST
collaborative study
Abstract
Background
Platelet components (PCs) with persistent aggregates are typically discarded. Few studies have charac...
Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia
Crebbp HAT Domain Mutations Are Frequently Detected in Adult Acute Lymphoblastic Leukemia
Abstract
Abstract 1419
Aims:
Molecular pathogenesis of acute lymphoblastic leukemia (ALL) has largely been verifi...

